Cerveau Lantheus
1 products tracked · names used in filings: Cerveau Lantheus
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Thu 13 Aug 2026🇺🇸 FDA approval
FDA approves Tauklarify (florquinitau f-18), a new medicine
Cerveau Lantheus; NDA220496; New molecular entity; solution · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Tauklarify florquinitau f-18 | Approved | 2026-08-13 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.